|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
66,921,000 |
Market
Cap: |
2.94(B) |
Last
Volume: |
1,212,774 |
Avg
Vol: |
1,003,203 |
52
Week Range: |
$38.26 - $89.25 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue, Lyra®, FreshCells, D3®, FastPoint®, ReadyCells®, Super E-Mix, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2019-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,706 |
44,898 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-02-11 |
4 |
D |
$60.75 |
$198,470 |
D/D |
(3,267) |
301,086 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,809 |
301,864 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2019-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,334 |
19,459 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2019-02-10 |
4 |
D |
$58.37 |
$24,807 |
D/D |
(425) |
42,868 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2019-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,201 |
43,293 |
|
- |
|
Russell Edward Keith |
S.V.P., N.A. Commercial Ops |
|
2019-02-10 |
4 |
D |
$58.37 |
$28,601 |
D/D |
(490) |
9,598 |
|
- |
|
Russell Edward Keith |
S.V.P., N.A. Commercial Ops |
|
2019-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,201 |
10,088 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2019-02-10 |
4 |
D |
$58.37 |
$24,749 |
D/D |
(424) |
17,562 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2019-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,201 |
17,986 |
|
- |
|
Abney Michael Donald Jr. |
SVP - Distribution |
|
2019-02-10 |
4 |
D |
$58.37 |
$17,044 |
D/D |
(292) |
14,134 |
|
- |
|
Abney Michael Donald Jr. |
SVP - Distribution |
|
2019-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,201 |
14,426 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-02-10 |
4 |
D |
$58.37 |
$92,692 |
D/D |
(1,588) |
297,544 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,203 |
299,132 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-02-10 |
4 |
D |
$58.37 |
$17,453 |
D/D |
(299) |
14,166 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
734 |
14,465 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2019-02-05 |
4 |
OE |
$14.43 |
$112,554 |
D/D |
7,800 |
37,428 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2019-02-05 |
4 |
D |
$59.00 |
$28,910 |
D/D |
(490) |
16,785 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,201 |
17,206 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-02-05 |
4 |
D |
$59.00 |
$17,700 |
D/D |
(300) |
13,731 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
734 |
13,868 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-02-05 |
4 |
D |
$59.00 |
$93,692 |
D/D |
(1,588) |
295,929 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,204 |
297,517 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2019-02-05 |
4 |
D |
$59.00 |
$28,910 |
D/D |
(490) |
42,092 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,201 |
42,582 |
|
- |
|
799 Records found
|
|
Page 15 of 32 |
|
|